查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1870987

人工颈椎间盘市场依产品类型、材质类型、最终用户和通路划分－2025-2032年全球预测

Artificial Cervical Intervertebral Disc Market by Product Type, Material Type, End User, Distribution Channel - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 183 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2032 年，人工颈椎间盘市场规模将达到 79 亿美元，复合年增长率为 18.33%。

关键市场统计数据
基准年 2024 20.5亿美元
预计年份：2025年 24.2亿美元
预测年份 2032 79亿美元
复合年增长率 (%) 18.33%

本文简要概述了影响人工颈椎间盘在各相关人员方中发展和应用的临床、技术和商业性因素。

人工颈椎间盘技术代表了整形外科领域的一个融合创新领域，它汇集了植入设计、生物材料科学、外科技术和医疗保健系统动态，旨在解决颈椎退化性疾病。运动保留装置的引入正在重塑传统上严重依赖融合手术的治疗路径，促使临床医生和医疗保健系统重新评估适应症、患者选择和长期功能预后。本导言以执行摘要为核心，整合了当前影响该领域的临床趋势、技术进步、监管发展和商业性因素。

材料创新、不断发展的外科技术和价值主导型采购如何共同作用，改变颈椎间盘植入装置的临床应用和商业策略

人工颈椎间盘领域经历了数次变革，这些变革加速了创新，同时也为商业化带来了新的挑战。首先，生物材料科学的成熟使得人工颈椎间盘的结构从传统的金属对金属结构过渡到含有高度交联聚合物配方的复合材料，旨在减少颗粒碎片并提高长期耐久性。材料技术的进步也推动了植入物几何形状的相应改进，设计者强调保持一致的关节活动度和限制活动范围，以在不影响稳定性的前提下保留生理运动。

评估美国关税调整对颈椎间盘供应弹性、定价策略和采购趋势的多方面影响

美国宣布的2025年关税调整对人工颈椎间盘生态系统产生了多方面的影响，波及供应链、定价策略和策略采购决策。对于依赖跨境采购原料、精密零件和成品的製造商而言，关税变化加剧了到岸成本的波动性，迫使其进行更积极的成本建模和情境规划。为此，许多公司正在重新审视其供应商组合，并加快近岸外包和在地化生产的步伐，以维持利润率并确保可预测的交货时间。

细分市场主导的策略挑战，将产品设计、生物材料选择、临床环境和分销模式与差异化的商业性成果连结起来。

市场区隔洞察揭示了产品、材料、终端用户和分销管道等各个维度上的差异化机会和针对性策略选择。从产品类型来看，球窝式人工椎间盘旨在提供可重复的旋转运动，可能适用于以维持多轴运动为优先考虑的适应症。缓衝式人工椎间盘着重于减震和负荷分布，适用于具有特定动态特征的患者。髓核置换式人工椎间盘旨在恢復局部椎间盘高度并将负荷转移至中心位置，适用于特定适应症。这些差异会影响临床定位、手术技术训练以及製造商优先考虑的疗效证据类型。

区域法规结构、临床能力和供应链生态系统如何影响关键全球区域的首选市场进入顺序和证据策略

临床实务、监管方式和供应链物流方面的区域差异，导致各主要地区在医疗器材应用趋势上有显着差异。在美洲，成熟的临床网络和以结果为导向的采购政策要求製造商证明其产品具有切实的功能优势和手术全期效率。报销机制和医院采购委员会主导医疗器材的选择，而区域供应链中心则支援快速分销和即时库存模式。同时，欧洲、中东和非洲地区的情况则更为复杂，各国监管路径、公共采购流程和私部门渗透率的差异，既为市场准入和规模化带来了机会，也带来了挑战。一些国家的国家卫生技术评估流程强调疗效比较数据和成本效益，引导製造商投资于针对特定国家的证据产生。

老牌企业与创新企业之间的竞争和策略行为会影响产品采纳曲线、证据产生和供应商联盟。

人工颈椎间盘市场的竞争格局呈现出多元化的特点，既有成熟的整形外科公司、脊椎器械专家，也有不断推出新材料和新设计概念的新兴创新者。现有企业拥有规模优势、製造技术专长和成熟的临床合作关係，并透过提供包括外科医生培训、器械消毒支援和资金筹措协助在内的广泛服务来维持市场份额。新兴企业则倾向于专注于临床差异化，例如新型聚合物组合、模组化设计或简化的器械，这些都可能为患者带来特定的手术和治疗益处。

一套综合性的实用策略倡议，旨在帮助製造商和供应商提升产品差异化、供应链韧性和实证商业化能力。

产业领导者应抓住机会，透过一系列协作努力，协调产品开发、实证实践和商业性韧性，从而扩大产品应用范围。首先，应优先考虑将临床差异化设计特征与具有成熟耐磨性和安全性的材料结合的开发路径。重点在于采用高交联聚乙烯 (HCPE) 或超高分子量聚乙烯 (UHMWPE) 的金属对聚合物 (MoP) 方案，既能解决临床医生关注的关键问题，又能支持长期疗效追踪。同时，应建构产品系列，并确保行销和培训活动与外科医生的工作流程和患者选择标准相符。

我们以透明的方式概述了我们的多源研究途径，该方法整合了临床医生意见、监管审查和商业性洞察，以检验策略见解。

本分析整合了对骨科医生、采购主管和供应链专业人员的访谈、对监管指南和临床文献的系统性回顾以及上市后数据趋势，从而全面了解人工颈椎间盘的动态变化。主要研究包括结构化访谈，检验临床应用案例，了解植入选择决策因素，并了解采购部门对近期关税变化的反应。次要研究则纳入了同行评审的临床文章、医疗设备标籤资讯和公开的监管文件，以确保与当前的安全性和有效性考虑保持一致。

整合相互依存的临床、商业性和政策因素，这些因素将决定颈椎间盘生态系统中的持续应用和策略定位。

总之，人工颈椎间盘的创新正在材料、动态、手术技术和商业策略等多个领域不断发展，为製造商、临床医生和医疗保健系统创造了一个充满活力的环境。聚合物技术的进步、精密的关节设计以及越来越多接受过运动功能保留手术培训的临床医生相互交织，共同推动人工颈椎间盘在特定患者群体中的选择性应用。同时，关税变化和区域监管差异等外部压力迫使供应商在製造地的策略布局、定价策略以及实证医学投入方面采取更具策略性的措施。

目录

第一章：序言

第二章调查方法

第三章执行摘要

第四章 市场概览

第五章 市场洞察

  • 用于提高颈椎间盘耐磨性的PEEK/金属复合材料的创新
  • 为恢復椎间盘高度，对新一代椎核置换方案的需求激增
  • 智慧感测器颈椎间盘的应用日益广泛，以实现术后运动追踪。
  • 扩大保险覆盖范围，以支持年轻患者接受人工颈全人工椎间盘置换术
  • 采用新型生物相容性水凝胶的颈椎间盘植入获得加速监管核准
  • 人们对使用3D列印技术特异性患者颈椎间盘以改善解剖结构贴合度的兴趣日益浓厚。
  • 临床上努力减少人工颈椎间盘植入术后邻近椎间盘的退化
  • 整形外科器械製造商与人工智慧公司合作，优化人工椎间盘的设计和性能
  • 越来越多的长期追踪研究评估颈椎人工椎间盘的磨损颗粒和骨溶解情况
  • 为颈椎人工椎间盘引入抗菌表面涂层，以最大限度降低术后感染风险

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章 人工颈椎间盘市场（依产品类型划分）

  • 球窝式人工椎间盘
  • 椎间盘呈垫状。
  • 髓核置换人工椎间盘

第九章 人工颈椎间盘市场（依材料类型划分）

  • 金属对金属
  • 金属与聚合物
    • 高交联聚乙烯
    • 超高分子量聚乙烯
  • 聚合物与聚合物

第十章 依最终用户分類的人工颈椎间盘市场

  • 门诊手术中心
  • 医院
    • 私立医院
    • 公立医院
  • 专业整形外科中心

第十一章 人工颈椎间盘市场（依通路划分）

  • 直销
  • 批发的

第十二章 人工颈椎间盘市场：依地区划分

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十三章 人工颈椎间盘市场（依组别划分）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十四章 各国人工颈椎间盘市场

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十五章 竞争格局

  • 2024年市占率分析
  • FPNV定位矩阵，2024
  • 竞争分析
    • DePuy Synthes, Inc.
    • Medtronic plc
    • Stryker Corporation
    • Zimmer Biomet Holdings, Inc.
    • NuVasive, Inc.
    • Globus Medical, Inc.
    • Orthofix Medical Inc.
    • Centinel Spine, LLC
    • B. Braun Melsungen AG
    • Medacta International SA
Product Code: MRR-1A1A064C053A

The Artificial Cervical Intervertebral Disc Market is projected to grow by USD 7.90 billion at a CAGR of 18.33% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 2.05 billion
Estimated Year [2025] USD 2.42 billion
Forecast Year [2032] USD 7.90 billion
CAGR (%) 18.33%

A concise framing of clinical, technological, and commercial drivers reshaping artificial cervical intervertebral disc development and adoption across stakeholder groups

Artificial cervical intervertebral disc technologies represent a convergent area of orthopedic innovation, where implant design, biomaterials science, surgical technique, and health system dynamics intersect to address degenerative cervical spine conditions. The introduction of motion-preserving devices has reframed therapeutic pathways that historically relied heavily on fusion, prompting clinicians and health systems to reassess indications, patient selection, and long-term functional outcomes. This introduction anchors an executive summary that synthesizes clinical trends, technology evolution, regulatory trajectories, and commercial forces shaping the segment today.

Over recent years, device designers have pursued refined articulating geometries, alternative material pairings, and modular constructs intended to optimize kinematics and reduce wear. Concurrently, surgeons have broadened their armamentarium by integrating cervical disc replacement into treatment algorithms for appropriate patient cohorts, while payers and hospitals evaluate comparative value versus fusion in terms of rehabilitation, adjacent segment disease, and resource utilization. This section frames the broader context in which product innovation and stakeholder decision-making occur, highlighting the interplay between clinical evidence generation, surgeon training, and procurement dynamics.

The remainder of the summary unpacks the most consequential shifts impacting adoption, the implications of recent tariff policies in the United States, segmentation-based insights that inform commercialization tactics, regional patterns in clinical practice and supply chain resilience, profiles of influential corporate players, recommended actions for industry leaders, and a transparent description of the methodology underpinning the analysis.

How materials innovation, surgical technique evolution, and value-driven procurement are jointly transforming clinical adoption and commercial strategies for cervical disc devices

The landscape for artificial cervical intervertebral discs has experienced several transformative shifts that collectively accelerate innovation while also introducing new complexity for commercialization. First, the maturation of biomaterials science has enabled a move beyond traditional metal-on-metal constructs toward polymer-inclusive pairings and highly cross-linked formulations designed to reduce particulate debris and improve long-term durability. These material advances have driven parallel refinements in implant geometry, with designers emphasizing congruent articulations and constrained mobility tailored to preserve physiological motion without compromising stability.

Second, surgical technique and perioperative pathways have evolved in tandem with device innovation. Surgeons are more systematically integrating preoperative imaging analytics and intraoperative navigation to optimize implant positioning and alignment, which in turn improves functional outcomes and device survival. Enhanced training programs and proctoring models have lowered the barriers to adoption among spine specialists, while multidisciplinary care pathways have refined patient selection criteria to better match device profile to clinical indication.

Third, reimbursement and value assessment paradigms are shifting toward evidence-based comparisons that consider total episode outcomes. Health systems increasingly emphasize comparative effectiveness studies and real-world evidence to inform procurement, which elevates the importance of post-market surveillance and registries. Lastly, supply chain agility and manufacturing scalability have become strategic priorities as firms balance regulatory compliance, cost pressures, and the need for geographically diversified production to mitigate logistic risks.

Evaluating the multifaceted consequences of the United States tariff adjustments on supply resilience, pricing strategy, and procurement dynamics within the cervical disc sector

Recent tariff adjustments announced in the United States in 2025 have imparted a multifaceted impact on the artificial cervical intervertebral disc ecosystem, influencing supply chains, pricing strategy, and strategic sourcing decisions. For manufacturers reliant on cross-border supply of raw materials, precision components, or finished devices, tariff changes have introduced additional landed cost variability that necessitates more proactive cost modeling and scenario planning. In response, many firms have re-evaluated their supplier portfolios and accelerated nearshoring or regional manufacturing initiatives to preserve margins and maintain predictable delivery timelines.

Procurement teams within hospitals and specialty centers have reacted by intensifying contract negotiations and by seeking greater transparency around total cost of care rather than focusing solely on unit price. As a result, vendors are emphasizing bundled service offerings, longer-term value propositions, and outcomes-based agreements that can mitigate the short-term pricing friction introduced by tariffs. At the same time, regulatory and customs compliance activities have scaled up within corporate functions to manage tariff classification risk and to identify eligible exemptions or free trade mechanisms.

Clinicians and hospital administrators have felt secondary effects as supply variability and cost pressures influence purchasing cadence and stocking policies. To maintain access to preferred implants, clinical teams have collaborated more closely with supply chain and finance partners to forecast case volumes and ensure continuity of care. Collectively, these shifts underscore the need for integrated commercial strategies that align pricing, supply resilience, and clinical value arguments in a tariff-sensitive operating environment.

Segment-driven strategic imperatives that connect product architectures, biomaterial selection, clinical settings, and distribution models to differentiated commercial outcomes

Insight into market segmentation reveals differentiated opportunities and targeted strategic choices across product, material, end user, and distribution dimensions. From a product type perspective, Ball And Socket Disc designs emphasize replicating rotational kinematics and may appeal where multi-axis motion preservation is prioritized, Cushion Disc architectures focus on shock absorption and load distribution suited to patients with particular biomechanical profiles, and Nucleus Replacement Disc concepts target focal restoration of disc height and central load transfer for select indications. These distinctions inform clinical positioning, surgical technique training, and the types of outcome evidence manufacturers prioritize.

Material type segmentation further refines design trade-offs. Metal On Metal constructs historically offered strength and low deformation but raised concerns about wear particles. Metal On Polymer combinations have become prominent because they offer a balance of strength and wear reduction, and within that grouping there is specific attention to Highly Cross-Linked Polyethylene and Ultra-High-Molecular-Weight Polyethylene as polymer options that improve wear characteristics and longevity. Polymer On Polymer pairings present an alternative route toward low-friction interfaces and have the potential to reduce metal exposure in sensitive patient populations.

End user segmentation reveals divergent procurement and utilization patterns. Ambulatory Surgical Centers often prioritize implants that enable streamlined procedural workflows and rapid recovery, Hospitals accommodate a broader case mix and encompass both Private Hospital and Public Hospital procurement dynamics that influence purchasing cycles and contract structures, while Specialty Orthopedic Centers demand devices supported by robust clinical evidence and surgeon training. Finally, distribution channel choices-Direct Sales versus Distributor Sales-shape commercial touchpoints, service models, and margin structures, and they influence how manufacturers deploy field clinical specialists, training curricula, and post-market surveillance programs.

How regional regulatory frameworks, clinical capacity, and supply chain ecosystems shape prioritized market entry sequencing and evidence strategies across major global geographies

Regional patterns in clinical practice, regulatory approaches, and supply chain logistics yield meaningful variation in adoption dynamics across major geographies. In the Americas, established clinical networks and a focus on outcome-driven procurement exert pressure on manufacturers to demonstrate tangible functional benefits and perioperative efficiencies; reimbursement frameworks and hospital purchasing committees shape device selection, while supply chain hubs in the region support rapid distribution and just-in-time inventory models. Meanwhile, Europe, Middle East & Africa presents a heterogeneous landscape where national regulatory pathways, public procurement processes, and varying levels of private sector penetration create both opportunities and complexity for market entry and scale-up. National health technology assessment processes in some countries emphasize comparative effectiveness data and cost-effectiveness, directing manufacturers to invest in country-specific evidence generation.

In the Asia-Pacific region, expanding surgical capacity, increasing procedure volumes, and a growing base of trained spine surgeons are contributing to a more dynamic market environment. Local manufacturing ecosystems and regional component suppliers offer pathways to cost-competitive production, while fragmented payer systems and disparate regulatory requirements necessitate tailored commercialization approaches. Across all regions, clinicians and health systems demonstrate greater appetite for data-driven decision-making, which amplifies the importance of post-market registries and multicenter outcome studies that can be leveraged to support reimbursement discussions and surgeon adoption strategies. These regional insights should inform prioritization of clinical studies, manufacturing footprints, and market entry sequencing.

Competitive dynamics and strategic behaviors among established firms and innovators that influence adoption curves, evidence generation, and supplier partnerships

The competitive fabric of the artificial cervical intervertebral disc landscape is characterized by a mix of established orthopedic firms, specialized spine device companies, and emerging innovators that introduce new materials and design philosophies. Incumbent players bring scale, manufacturing expertise, and established clinical relationships, and they often leverage broad service offerings such as surgeon education, instrument sterilization support, and financing arrangements to maintain share. Emerging companies frequently compete on focused clinical differentiation-such as novel polymer pairings, modularity, or simplified instrumentation-that can deliver specific surgical or patient benefits.

Strategic activity among these companies includes progressive clinical evidence generation, targeted post-market studies, and iterative product refinements based on real-world feedback. Partnerships and selective licensing agreements are common pathways for mid-sized firms seeking to access global distribution networks or to complement their R&D capabilities. At the same time, several players are investing in digital capabilities that enhance implant tracking, patient-reported outcome capture, and remote follow-up, thereby strengthening long-term value propositions. For purchasers and hospital systems, evaluating vendor ecosystems now requires attention not only to implant performance but also to the breadth of clinician support, registry participation, and the supplier's ability to navigate tariff-impacted supply chains and local regulatory requirements.

An integrated set of pragmatic and strategic actions for manufacturers and suppliers to strengthen product differentiation, supply chain resilience, and evidence-backed commercialization

Industry leaders should pursue a set of coordinated actions that align product development, evidence generation, and commercial resilience to capitalize on evolving adoption windows. First, prioritize development paths that marry clinically differentiated design features with materials that offer demonstrable wear and safety benefits; focusing on Metal On Polymer options that utilize Highly Cross-Linked Polyethylene or Ultra-High-Molecular-Weight Polyethylene can address key clinician concerns while supporting longer-term outcomes tracking. Simultaneously, tailor product portfolios to reflect the clinical nuances among Ball And Socket Disc, Cushion Disc, and Nucleus Replacement Disc archetypes so that marketing and training efforts are congruent with surgeon workflows and patient selection criteria.

Second, fortify supply chain and tariff risk management by diversifying supplier bases, evaluating regional manufacturing partnerships, and embedding customs and trade expertise into commercial planning. Third, strengthen post-market evidence generation through registries and multicenter collaborations that span key regions, enhancing the ability to engage payers and hospital systems with comparative effectiveness insights. Fourth, adapt go-to-market models by balancing Direct Sales investments with selective Distributor Sales where partners can provide local regulatory navigation and inventory support, thereby enabling broader reach while preserving high-quality clinician engagement.

Finally, invest in digital tools and services that improve the clinician experience, facilitate patient follow-up, and provide outcome analytics that support reimbursement conversations. By executing these actions in an integrated manner, organizations can create defensible pathways for adoption that withstand pricing and policy pressures while delivering demonstrable clinical value.

A transparent overview of the multi-source research approach that integrates clinician input, regulatory review, and commercial intelligence to validate strategic insights

This analysis synthesizes primary interviews with orthopedic surgeons, procurement leaders, and supply chain specialists, structured reviews of regulatory guidance and clinical literature, and post-market data trends to construct a comprehensive perspective on artificial cervical intervertebral disc dynamics. Primary engagement included structured conversations to validate clinical use cases, understand decision drivers for implant selection, and capture procurement responses to recent tariff changes. Secondary research incorporated peer-reviewed clinical publications, device labeling information, and publicly available regulatory communications to ensure alignment with current safety and efficacy considerations.

The methodological approach intentionally layered qualitative insights with observed commercial behaviors to reconcile surgeon preferences, hospital purchasing patterns, and regional regulatory nuances. Segmentation analysis drew on clinical device attributes and established distribution models to delineate where differentiated product strategies and market access investments deliver the greatest returns. Regional analysis integrated local practice patterns and manufacturing footprints to identify pragmatic pathways for scaling distribution and evidence generation. Throughout the research process, findings were triangulated across sources to enhance validity and to provide actionable guidance for decision-makers focused on clinical adoption, supply resilience, and long-term value delivery.

A synthesis of the interdependent clinical, commercial, and policy factors that will determine durable adoption and strategic positioning in the cervical disc ecosystem

In conclusion, artificial cervical intervertebral disc innovation is advancing on multiple fronts-materials, biomechanics, surgical technique, and commercial strategy-creating a dynamic environment for manufacturers, clinicians, and health systems. The interplay between improved polymer technologies, refined articulating designs, and an expanding clinician base trained in motion-preserving procedures supports selective adoption across appropriate patient populations. At the same time, external pressures such as tariff changes and regional regulatory diversity require vendors to be more strategic about manufacturing footprints, pricing approaches, and evidence generation investments.

Decision-makers should view these dynamics as an opportunity to differentiate through demonstrable clinical value, robust post-market surveillance, and flexible commercial models that address both Direct Sales and Distributor Sales channels. By aligning product development with the clinical realities of Ball And Socket Disc, Cushion Disc, and Nucleus Replacement Disc use cases, and by prioritizing material choices that improve wear characteristics, organizations can strengthen their propositions to hospitals, ambulatory centers, and specialty orthopedic providers. Ultimately, success will hinge on the ability to integrate clinical excellence with supply chain foresight and payer-aligned evidence strategies to secure durable adoption and improved patient outcomes.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Innovation in PEEK-on-metal composites for enhanced wear resistance in cervical discs
  • 5.2. Surge in demand for next-generation nucleus replacement options to restore disc height
  • 5.3. Increased adoption of smart sensor-enabled cervical discs for postoperative motion tracking
  • 5.4. Expansion of insurance coverage policies supporting artificial cervical disc replacement in younger patients
  • 5.5. Regulatory fast-track approvals for novel biocompatible hydrogels in cervical disc implants
  • 5.6. Growing interest in patient-specific 3D printed cervical discs to improve anatomical fit
  • 5.7. Clinical focus on reducing adjacent segment degeneration following artificial cervical disc implantation
  • 5.8. Collaborations between orthopedic device makers and AI firms to optimize disc design and performance
  • 5.9. Rising number of long-term outcome studies evaluating wear particles and osteolysis in cervical discs
  • 5.10. Emergence of antibacterial surface coatings on cervical discs to minimize postoperative infection risks

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Artificial Cervical Intervertebral Disc Market, by Product Type

  • 8.1. Ball And Socket Disc
  • 8.2. Cushion Disc
  • 8.3. Nucleus Replacement Disc

9. Artificial Cervical Intervertebral Disc Market, by Material Type

  • 9.1. Metal On Metal
  • 9.2. Metal On Polymer
    • 9.2.1. Highly Cross-Linked Polyethylene
    • 9.2.2. Ultra-High-Molecular-Weight Polyethylene
  • 9.3. Polymer On Polymer

10. Artificial Cervical Intervertebral Disc Market, by End User

  • 10.1. Ambulatory Surgical Center
  • 10.2. Hospital
    • 10.2.1. Private Hospital
    • 10.2.2. Public Hospital
  • 10.3. Specialty Orthopedic Center

11. Artificial Cervical Intervertebral Disc Market, by Distribution Channel

  • 11.1. Direct Sales
  • 11.2. Distributor Sales

12. Artificial Cervical Intervertebral Disc Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Artificial Cervical Intervertebral Disc Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Artificial Cervical Intervertebral Disc Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. Competitive Landscape

  • 15.1. Market Share Analysis, 2024
  • 15.2. FPNV Positioning Matrix, 2024
  • 15.3. Competitive Analysis
    • 15.3.1. DePuy Synthes, Inc.
    • 15.3.2. Medtronic plc
    • 15.3.3. Stryker Corporation
    • 15.3.4. Zimmer Biomet Holdings, Inc.
    • 15.3.5. NuVasive, Inc.
    • 15.3.6. Globus Medical, Inc.
    • 15.3.7. Orthofix Medical Inc.
    • 15.3.8. Centinel Spine, LLC
    • 15.3.9. B. Braun Melsungen AG
    • 15.3.10. Medacta International SA

LIST OF FIGURES

  • FIGURE 1. GLOBAL ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY MATERIAL TYPE, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY MATERIAL TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 11. AMERICAS ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. NORTH AMERICA ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. LATIN AMERICA ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. EUROPE ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. MIDDLE EAST ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. AFRICA ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. GLOBAL ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASEAN ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GCC ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. EUROPEAN UNION ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. BRICS ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. G7 ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. NATO ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. GLOBAL ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 28. ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY BALL AND SOCKET DISC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY BALL AND SOCKET DISC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY BALL AND SOCKET DISC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY BALL AND SOCKET DISC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY BALL AND SOCKET DISC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY BALL AND SOCKET DISC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY CUSHION DISC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY CUSHION DISC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY CUSHION DISC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY CUSHION DISC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY CUSHION DISC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY CUSHION DISC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY NUCLEUS REPLACEMENT DISC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY NUCLEUS REPLACEMENT DISC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY NUCLEUS REPLACEMENT DISC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY NUCLEUS REPLACEMENT DISC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY NUCLEUS REPLACEMENT DISC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY NUCLEUS REPLACEMENT DISC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY MATERIAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY METAL ON METAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY METAL ON METAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY METAL ON METAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY METAL ON METAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY METAL ON METAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY METAL ON METAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY METAL ON POLYMER, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY METAL ON POLYMER, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY METAL ON POLYMER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY METAL ON POLYMER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY METAL ON POLYMER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY METAL ON POLYMER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY METAL ON POLYMER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY METAL ON POLYMER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY HIGHLY CROSS-LINKED POLYETHYLENE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY HIGHLY CROSS-LINKED POLYETHYLENE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY HIGHLY CROSS-LINKED POLYETHYLENE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY HIGHLY CROSS-LINKED POLYETHYLENE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY HIGHLY CROSS-LINKED POLYETHYLENE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY HIGHLY CROSS-LINKED POLYETHYLENE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY ULTRA-HIGH-MOLECULAR-WEIGHT POLYETHYLENE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY ULTRA-HIGH-MOLECULAR-WEIGHT POLYETHYLENE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY ULTRA-HIGH-MOLECULAR-WEIGHT POLYETHYLENE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY ULTRA-HIGH-MOLECULAR-WEIGHT POLYETHYLENE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY ULTRA-HIGH-MOLECULAR-WEIGHT POLYETHYLENE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY ULTRA-HIGH-MOLECULAR-WEIGHT POLYETHYLENE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY POLYMER ON POLYMER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY POLYMER ON POLYMER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY POLYMER ON POLYMER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY POLYMER ON POLYMER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY POLYMER ON POLYMER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY POLYMER ON POLYMER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY HOSPITAL, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY HOSPITAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY HOSPITAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY HOSPITAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY HOSPITAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY HOSPITAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY PRIVATE HOSPITAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY PRIVATE HOSPITAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY PRIVATE HOSPITAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY PRIVATE HOSPITAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY PRIVATE HOSPITAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY PRIVATE HOSPITAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY PUBLIC HOSPITAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY PUBLIC HOSPITAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY PUBLIC HOSPITAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY PUBLIC HOSPITAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY PUBLIC HOSPITAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY PUBLIC HOSPITAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY SPECIALTY ORTHOPEDIC CENTER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY SPECIALTY ORTHOPEDIC CENTER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY SPECIALTY ORTHOPEDIC CENTER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY SPECIALTY ORTHOPEDIC CENTER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY SPECIALTY ORTHOPEDIC CENTER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY SPECIALTY ORTHOPEDIC CENTER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY DIRECT SALES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY DIRECT SALES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY DIRECT SALES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY DISTRIBUTOR SALES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY DISTRIBUTOR SALES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY DISTRIBUTOR SALES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY DISTRIBUTOR SALES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY DISTRIBUTOR SALES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY DISTRIBUTOR SALES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 109. AMERICAS ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 110. AMERICAS ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 111. AMERICAS ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 112. AMERICAS ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 113. AMERICAS ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 114. AMERICAS ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY MATERIAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 115. AMERICAS ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY METAL ON POLYMER, 2018-2024 (USD MILLION)
  • TABLE 116. AMERICAS ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY METAL ON POLYMER, 2025-2032 (USD MILLION)
  • TABLE 117. AMERICAS ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 118. AMERICAS ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 119. AMERICAS ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
  • TABLE 120. AMERICAS ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY HOSPITAL, 2025-2032 (USD MILLION)
  • TABLE 121. AMERICAS ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 122. AMERICAS ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 123. NORTH AMERICA ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 124. NORTH AMERICA ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 125. NORTH AMERICA ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 126. NORTH AMERICA ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 127. NORTH AMERICA ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 128. NORTH AMERICA ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY MATERIAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 129. NORTH AMERICA ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY METAL ON POLYMER, 2018-2024 (USD MILLION)
  • TABLE 130. NORTH AMERICA ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY METAL ON POLYMER, 2025-2032 (USD MILLION)
  • TABLE 131. NORTH AMERICA ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 132. NORTH AMERICA ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 133. NORTH AMERICA ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
  • TABLE 134. NORTH AMERICA ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY HOSPITAL, 2025-2032 (USD MILLION)
  • TABLE 135. NORTH AMERICA ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 136. NORTH AMERICA ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 137. LATIN AMERICA ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 138. LATIN AMERICA ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 139. LATIN AMERICA ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 140. LATIN AMERICA ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 141. LATIN AMERICA ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 142. LATIN AMERICA ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY MATERIAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 143. LATIN AMERICA ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY METAL ON POLYMER, 2018-2024 (USD MILLION)
  • TABLE 144. LATIN AMERICA ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY METAL ON POLYMER, 2025-2032 (USD MILLION)
  • TABLE 145. LATIN AMERICA ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 146. LATIN AMERICA ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 147. LATIN AMERICA ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
  • TABLE 148. LATIN AMERICA ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY HOSPITAL, 2025-2032 (USD MILLION)
  • TABLE 149. LATIN AMERICA ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 150. LATIN AMERICA ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 151. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 152. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 153. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 154. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 155. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 156. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY MATERIAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 157. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY METAL ON POLYMER, 2018-2024 (USD MILLION)
  • TABLE 158. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY METAL ON POLYMER, 2025-2032 (USD MILLION)
  • TABLE 159. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 160. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 161. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
  • TABLE 162. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY HOSPITAL, 2025-2032 (USD MILLION)
  • TABLE 163. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 164. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 165. EUROPE ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 166. EUROPE ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 167. EUROPE ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 168. EUROPE ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 169. EUROPE ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 170. EUROPE ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY MATERIAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 171. EUROPE ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY METAL ON POLYMER, 2018-2024 (USD MILLION)
  • TABLE 172. EUROPE ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY METAL ON POLYMER, 2025-2032 (USD MILLION)
  • TABLE 173. EUROPE ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 174. EUROPE ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 175. EUROPE ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
  • TABLE 176. EUROPE ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY HOSPITAL, 2025-2032 (USD MILLION)
  • TABLE 177. EUROPE ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 178. EUROPE ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 179. MIDDLE EAST ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 180. MIDDLE EAST ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 181. MIDDLE EAST ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 182. MIDDLE EAST ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 183. MIDDLE EAST ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 184. MIDDLE EAST ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY MATERIAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 185. MIDDLE EAST ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY METAL ON POLYMER, 2018-2024 (USD MILLION)
  • TABLE 186. MIDDLE EAST ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY METAL ON POLYMER, 2025-2032 (USD MILLION)
  • TABLE 187. MIDDLE EAST ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 188. MIDDLE EAST ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 189. MIDDLE EAST ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
  • TABLE 190. MIDDLE EAST ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY HOSPITAL, 2025-2032 (USD MILLION)
  • TABLE 191. MIDDLE EAST ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 192. MIDDLE EAST ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 193. AFRICA ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 194. AFRICA ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 195. AFRICA ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 196. AFRICA ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 197. AFRICA ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 198. AFRICA ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY MATERIAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 199. AFRICA ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY METAL ON POLYMER, 2018-2024 (USD MILLION)
  • TABLE 200. AFRICA ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY METAL ON POLYMER, 2025-2032 (USD MILLION)
  • TABLE 201. AFRICA ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 202. AFRICA ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 203. AFRICA ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
  • TABLE 204. AFRICA ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY HOSPITAL, 2025-2032 (USD MILLION)
  • TABLE 205. AFRICA ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 206. AFRICA ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 207. ASIA-PACIFIC ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 208. ASIA-PACIFIC ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 209. ASIA-PACIFIC ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 210. ASIA-PACIFIC ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 211. ASIA-PACIFIC ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 212. ASIA-PACIFIC ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY MATERIAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 213. ASIA-PACIFIC ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY METAL ON POLYMER, 2018-2024 (USD MILLION)
  • TABLE 214. ASIA-PACIFIC ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY METAL ON POLYMER, 2025-2032 (USD MILLION)
  • TABLE 215. ASIA-PACIFIC ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 216. ASIA-PACIFIC ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 217. ASIA-PACIFIC ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
  • TABLE 218. ASIA-PACIFIC ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY HOSPITAL, 2025-2032 (USD MILLION)
  • TABLE 219. ASIA-PACIFIC ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 220. ASIA-PACIFIC ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 221. GLOBAL ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 222. GLOBAL ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 223. ASEAN ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 224. ASEAN ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 225. ASEAN ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 226. ASEAN ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 227. ASEAN ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 228. ASEAN ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY MATERIAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 229. ASEAN ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY METAL ON POLYMER, 2018-2024 (USD MILLION)
  • TABLE 230. ASEAN ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY METAL ON POLYMER, 2025-2032 (USD MILLION)
  • TABLE 231. ASEAN ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 232. ASEAN ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 233. ASEAN ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
  • TABLE 234. ASEAN ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY HOSPITAL, 2025-2032 (USD MILLION)
  • TABLE 235. ASEAN ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 236. ASEAN ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 237. GCC ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 238. GCC ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 239. GCC ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 240. GCC ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 241. GCC ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 242. GCC ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY MATERIAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 243. GCC ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY METAL ON POLYMER, 2018-2024 (USD MILLION)
  • TABLE 244. GCC ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY METAL ON POLYMER, 2025-2032 (USD MILLION)
  • TABLE 245. GCC ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 246. GCC ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 247. GCC ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
  • TABLE 248. GCC ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY HOSPITAL, 2025-2032 (USD MILLION)
  • TABLE 249. GCC ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 250. GCC ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 251. EUROPEAN UNION ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 252. EUROPEAN UNION ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 253. EUROPEAN UNION ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 254. EUROPEAN UNION ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 255. EUROPEAN UNION ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 256. EUROPEAN UNION ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY MATERIAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 257. EUROPEAN UNION ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY METAL ON POLYMER, 2018-2024 (USD MILLION)
  • TABLE 258. EUROPEAN UNION ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY METAL ON POLYMER, 2025-2032 (USD MILLION)
  • TABLE 259. EUROPEAN UNION ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 260. EUROPEAN UNION ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 261. EUROPEAN UNION ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
  • TABLE 262. EUROPEAN UNION ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY HOSPITAL, 2025-2032 (USD MILLION)
  • TABLE 263. EUROPEAN UNION ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 264. EUROPEAN UNION ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 265. BRICS ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 266. BRICS ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 267. BRICS ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 268. BRICS ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 269. BRICS ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 270. BRICS ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY MATERIAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 271. BRICS ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY METAL ON POLYMER, 2018-2024 (USD MILLION)
  • TABLE 272. BRICS ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY METAL ON POLYMER, 2025-2032 (USD MILLION)
  • TABLE 273. BRICS ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)

TAB